medigraphic.com

2019, Number 2

Next >>

Rev Clin Esc Med 2019; 9 (2)

Abordaje en el servicio de emergencias de la infección por Neisseria meningitidis

Villalobos ZM, Vásquez JS, Arias DF, Mora AM, Vega CJC

Language: Spanish
References: 30
Page: 1-9
PDF size: 700.28 Kb.


ABSTRACT

Meningoccocal disease is one of the leading causes of death in children and adults in emergency services. The presence of nonspecific symptoms as headache, fever and myalgias can cause delayed diagnosis, mainly due to a late start of antibiotics, thus producing an increase in morbidity and mortality and disabling potential among those who survived the disease, due to the long-term neurological damage. On the other hand, the presence of a petechial skin rash in a critically ill patient or with meningeal signs should remind us of acute meningoccemia, and the approach of these patients should never be delayed due to its high mortality. In the emergency room should always be considered the isolation from secretions by drops of those patients with suspected meningococcal disease or with a confirmed diagnosis, as well as adequate prophylactic antibiotic therapy must be start immediately to those who had direct contact with patient´s nasopharyngeal secretions.


REFERENCES

  1. Siqueira R Gomes A Dutra J et al. Meningococcal disease, a clinical and epidemiological review. Asian Pacific Journal of Tropical Medicine. 2017; 10 (11): 1019-1029.

  2. Organización Mundial de la Salud. Meningitis meningoccocica. Recuperado de http://www.who.int/es/ news-room/fact-sheets/detail/meningococcal-meningitis. Accesado 19 de febrero 2018.

  3. Yazdankhah S Caugant D. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol. 2004; 53:821.

  4. 4.Apicella M. Clinical manifestations of meningococcal infection. Up to Date, 2018.

  5. Apicella M. Epidemiology of Neisseria meningitidis infection. Up to Date, 2018.

  6. Wong VK Hitchcock W Mason WH. Meningococcal infections in children: a review of 100 cases. Pediatr Infect Dis J. 1989;8(4):224.

  7. 7.Chanto G. Informe de vigilancia basada en laboratorio: “Vigilancia de laboratorio de Neisseria meningitidis, Costa Rica 2006 – 2015”. Tres Ríos, Costa Rica: INCIENSA, 2016.

  8. Siqueira R Gomes A Igreja R Huggins D. Medicina tropical: Abordagem atual das doenças infecciosas e parasitárias. Editora Cultura Médica. 2001. 521-549

  9. Jameson J Fauci AS Kasper DL Hauser SL Longo DL Loscalzo J. Harrison’s Principles of Internal Medicine. McGraw-Hill, New York. 20th ed, 2012; Cap 143: pp:1215.

  10. Van de Beek D de Gans J Tunkel A Wijdicks E. Community-Acquired Bacterial Meningitisin Adults. N Engl J Med. 2006;354(1):44-53.

  11. Heckenberg SG de Gans J Brouwer MC Weisfelt M et al. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore). 2008;87(4):185-192.

  12. Roos KL Tyler KL. Acute Meningitis. Harrison’s Principles of Internal Medicine. McGraw-Hill, New York. 20th ed, 2018.

  13. Kaye ET Kaye KM. Fiebre y exantema. Harrison. Principios de Medicina Interna. McGraw-Hill, New York. 18 ed, 2008; vol 2: 148-158 .

  14. Carpenter RR Petersdorf RG. The clinical spectrum of bacterial meningitis. Am J Med. 1962; 33:262.

  15. Thompson MJ Ninis N Perera R Mayon-White R et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397- 403.

  16. Strelow V Vidal J. Invasive meningococcal disease. Arq Neuropsiquiatr. 2013; 71 (9B):653-658

  17. Stephens DS Apicella MA. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Neisseria meningitidis. 8va edición. Elsevier Saunders. 2015; 2425-2445

  18. Pathan N Faust S Levin M. Pathophysiology of meningococcal meningitis and septicemia. Arch Dis Child. 2003; 88 (7): 601-607.

  19. Apicella M. Diagnosis of meningococcal infection. Up to Date, 2018

  20. Dwilow R Fanella S. Invasive meningococcal disease in the 21st century—an update for the clinician. Curr Neurol Neurosci Rep. 2015;15(3):2

  21. Barlam TF Kasper DL. Estudio del paciente febril con infección aguda. Harrison. Principios de Medicina. Interna. McGraw-Hill Education, New York. 20thed, 2018.

  22. Perez G Parra A Casimir L Mastroianni A Reijtman V Lopardo H et al. Infecciones invasivas por Streptococcuspneumoniae en un hospital pediátrico de tercernivel antes de la introducción de la vacunaconjugada. Características clínicas y serotipos involucrados. Arch Argent Pediatr 2013;111(3):202-205.

  23. Kasper DL Fauci AS Hauser SL Longo DL Lameson JL, Loscalzo J. Harrison’s Principles of Internal Medicine. McGraw-Hill Education, New York. 19 th ed. 2015; pp: 736–73

  24. Dynamed [internet]. Meningococcal disease. 2018. Recuperado de: https://www.dynamed.com/topics/ dmp~AN~T116912/Meningococcal-disease#Testingoverview. Accesado el 22 de septiembre 2018.

  25. Bosis S Mayer A Esposito S. Meningococcal disease in childhood: epidemiology, clinical features and prevention. J Prev Med Hyg. 201556(3):121-124.

  26. Collard JM Wang X Mahamane AE et al. A five-year field assessment of rapid diagnostic tests for meningococcal meningitis in Niger by using the combination of conventional and real-time PCR assays as a gold standard. Trans R Soc Trop Med Hyg. 2014; 108(1):6-12.

  27. Apicella M 2018. Treatment and prevention of meningococcal infection. Up to Date, 2018.

  28. Kaufman D Mancebo J. Glucocorticoid therapy in septic shock. Up to Date, 2018.

  29. Cohn AC MacNeil JR Clark TA et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62:1.

  30. Swiftwater PA. Menactra vaccine [Prescribing Information]. Sanofi Pasteur Inc.; 201. Recuperado de http://www.menactra.com. Accesado el 24 de febrero de 2019.




2020     |     www.medigraphic.com